A phase 2, single-arm study of volociximab monotherapy in subjects with platinum-resistant advanced epithelial ovarian cancer or primary peritoneal cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2015
At a glance
- Drugs Volociximab (Primary)
- Indications Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- Sponsors Abbott Biotherapeutics Corp
- 07 Jul 2012 Additional trial location added as reported by European Clinical Trials Database.
- 12 Mar 2012 Additional trial location added as reported by ClinicalTrials.gov.
- 12 Mar 2012 Actual patient number is 16 as reported by ClinicalTrials.gov.